← Evidence map

ArticlemAbs2019

Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity.

Kristina Ellwanger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

47 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31172847